157 related articles for article (PubMed ID: 7665812)
21. Non-involvement of ras mutations in flat colorectal adenomas and carcinomas.
Fujimori T; Satonaka K; Yamamura-Idei Y; Nagasako K; Maeda S
Int J Cancer; 1994 Apr; 57(1):51-5. PubMed ID: 8150541
[TBL] [Abstract][Full Text] [Related]
22. Polypoid growth and K-ras codon 12 mutation in colorectal cancer.
Yamagata S; Muto T; Uchida Y; Masaki T; Higuchi Y; Sawada T; Hirooka T
Cancer; 1995 Feb; 75(4):953-7. PubMed ID: 7842415
[TBL] [Abstract][Full Text] [Related]
23. Activation of the ras genes in malignant and premalignant colorectal tumors.
Glarakis IS; Savva S; Spandidos DA
Oncol Rep; 1998; 5(6):1451-4. PubMed ID: 9769386
[TBL] [Abstract][Full Text] [Related]
24. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
25. Analysis of ras gene mutations in gastrointestinal cancers.
Shen C; Chang JG; Lee LS; Yang MJ; Chen TC; Lin KY; Lee MD; Chen PH
J Formos Med Assoc; 1991 Dec; 90(12):1149-54. PubMed ID: 1686883
[TBL] [Abstract][Full Text] [Related]
26. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
[TBL] [Abstract][Full Text] [Related]
27. A detailed analysis of K-ras point mutations in relation to tumor progression and survival in colorectal cancer patients.
Span M; Moerkerk PT; De Goeij AF; Arends JW
Int J Cancer; 1996 Jun; 69(3):241-5. PubMed ID: 8682594
[TBL] [Abstract][Full Text] [Related]
28. Analysis of p53 abnormalities in endoscopic gastric biopsies.
Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
[TBL] [Abstract][Full Text] [Related]
29. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
De Benedetti L; Varesco L; Pellegata NS; Losi L; Gismondi V; Casarino L; Sciallero S; Bonelli L; Biticchi R; Bafico A
Anticancer Res; 1993; 13(3):667-70. PubMed ID: 8317895
[TBL] [Abstract][Full Text] [Related]
30. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632
[TBL] [Abstract][Full Text] [Related]
31. Natural history of colorectal nonpolypoid adenomas: a prospective colonoscopic study and relation with cell kinetics and K-ras mutations.
Watari J; Saitoh Y; Obara T; Fujiya M; Maemoto A; Ayabe T; Ashida T; Yokota K; Orii Y; Kohgo Y
Am J Gastroenterol; 2002 Aug; 97(8):2109-15. PubMed ID: 12190185
[TBL] [Abstract][Full Text] [Related]
32. p53 mutations in sporadic adrenocortical tumors.
Ohgaki H; Kleihues P; Heitz PU
Int J Cancer; 1993 May; 54(3):408-10. PubMed ID: 8509216
[TBL] [Abstract][Full Text] [Related]
33. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
[TBL] [Abstract][Full Text] [Related]
34. Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR.
Nollau P; Moser C; Weinland G; Wagener C
Int J Cancer; 1996 May; 66(3):332-6. PubMed ID: 8621253
[TBL] [Abstract][Full Text] [Related]
35. Detection of tumor cells in blood using CD45 magnetic cell separation followed by nested mutant allele-specific amplification of p53 and K-ras genes in patients with colorectal cancer.
Iinuma H; Okinaga K; Adachi M; Suda K; Sekine T; Sakagawa K; Baba Y; Tamura J; Kumagai H; Ida A
Int J Cancer; 2000 Jul; 89(4):337-44. PubMed ID: 10956407
[TBL] [Abstract][Full Text] [Related]
36. "Hot spots" mutation analysis of p53 gene in gastrointestinal cancers by amplification of naturally occurring and artificially created restriction sites.
Chen PH; Lin SY; Wang CK; Chen YJ; Chen TC; Chang JG
Clin Chem; 1993 Oct; 39(10):2186-91. PubMed ID: 7691445
[TBL] [Abstract][Full Text] [Related]
37. High frequency of ras mutations in forestomach and lung tumors of B6C3F1 mice exposed to 1-amino-2,4-dibromoanthraquinone for 2 years.
Hayashi S; Hong HH; Toyoda K; Ton TV; Devereux TR; Maronpot RR; Huff J; Sills RC
Toxicol Pathol; 2001; 29(4):422-9. PubMed ID: 11560247
[TBL] [Abstract][Full Text] [Related]
38. K-ras and p53 gene mutations in colorectal cancer in 57 Japanese patients.
Onda M; Abe R; Tsuchiya A; Fukushima T; Ando Y; Yoshida T
Fukushima J Med Sci; 1997 Jun; 43(1):29-39. PubMed ID: 9431782
[TBL] [Abstract][Full Text] [Related]
39. Clonal analysis of colorectal tumors using K-ras and p53 gene mutations as markers.
Dix BR; Robbins PD; Spagnolo DV; Padovan GL; House AK; Iacopetta BJ
Diagn Mol Pathol; 1995 Dec; 4(4):261-5. PubMed ID: 8634782
[TBL] [Abstract][Full Text] [Related]
40. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
